Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | Key steps to improve opportunities for gene therapy in patients with hemophilia

Brian O’Mahony • 11 Jul 2022
ISTH 2022
Hemophilia Non-Malignant

Brian O’Mahony, Irish Haemophilia Society, Dublin, Ireland, briefly highlights some key steps to improve gene therapy clinical trial treatment opportunities for patients with hemophilia. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

More from Brian O’Mahony

0:50
Empowering patients with hemophilia to make choices about gene therapy
Brian O’Mahony • 11 Jul 2022
0:44
The role of social media in patient advocacy in hemophilia
Brian O’Mahony • 11 Jul 2022
1:00
International collaborations working to improve hemophilia care
Brian O’Mahony • 11 Jul 2022
0:43
The importance of liver health in patients participating in hemophilia gene therapy clinical trials
Brian O’Mahony • 11 Jul 2022

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals